209 related articles for article (PubMed ID: 24080883)
1. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R
Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883
[No Abstract] [Full Text] [Related]
2. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Lange CM; Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
[No Abstract] [Full Text] [Related]
3. [New times for the treatment of chronic hepatitis C].
Gerstoft J; Fomsgaard A
Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
[No Abstract] [Full Text] [Related]
4. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
Bublak R
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
[No Abstract] [Full Text] [Related]
5. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
6. [Hepatitis C update: what has changed? What can we expect in the near future?].
Geier A
MMW Fortschr Med; 2013 Nov; 155(19):59-62. PubMed ID: 24475674
[No Abstract] [Full Text] [Related]
7. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
Manns M
MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
[No Abstract] [Full Text] [Related]
8. Viral hepatitis C in 2014--the beginning of the end?
Prelipcean CC; Gogălniceanu P; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
[No Abstract] [Full Text] [Related]
9. [Treatment of hepatitis C infection. A revolution should not hide another].
Sogni P
Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837
[No Abstract] [Full Text] [Related]
10. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
11. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
Marks KM; Jacobson IM
Antivir Ther; 2012; 17(6 Pt B):1119-31. PubMed ID: 23188750
[TBL] [Abstract][Full Text] [Related]
12. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.
Ghany MG; Nelson DR; Strader DB; Thomas DL; Seeff LB;
Hepatology; 2011 Oct; 54(4):1433-44. PubMed ID: 21898493
[No Abstract] [Full Text] [Related]
13. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Gellad ZF; Reed SD; Muir AJ
Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
[TBL] [Abstract][Full Text] [Related]
14. Excitement grows for potential revolution in hepatitis C virus treatment.
Opar A
Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
[No Abstract] [Full Text] [Related]
15. Antiviral agents and hepatitis C.
Archer-Festa M; Nilsen-Kupsch S
N Y State Dent J; 2012; 78(4):42-5. PubMed ID: 23252194
[TBL] [Abstract][Full Text] [Related]
16. New developments in HCV therapy.
Kronenberger B; Zeuzem S
J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitors in hepatitis C: from chronic disease to cure.
Iqbal M; McCormick PA
Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874
[No Abstract] [Full Text] [Related]
18. [New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed].
Lennerstrand J; Bondeson K; Bergqvist A; Blomberg J; Oberg B
Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3254-6, 3258, 3260. PubMed ID: 20101837
[No Abstract] [Full Text] [Related]
19. Direct-acting antiviral (DAA) actions in treatment-naïve patients.
Hézode C
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S52-8. PubMed ID: 22248695
[TBL] [Abstract][Full Text] [Related]
20. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
